ukmla MCQ (SBA): COPD inhaled therapy

Instant feedback + full explanation. One question, done properly.

MediumRespiratory MedicineCOPD inhaled therapyukmlamrcgp aktpanemrcp part 1

A 58-year-old man with COPD (FEV₁ 48% predicted) has persistent breathlessness despite SABA/SAMA. Non-exacerbator phenotype. Next inhaled step?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: COPD inhaled therapy — Answer & Explanation | iatroX